Bihar worst in genomic sampling, UP second lowest in India, shows data

11 of the 36 states/UTs have tested fewer samples than the national average

testing
Representational image (Photo: Reuters)
Ishaan Gera
1 min read Last Updated : Mar 30 2022 | 9:59 PM IST
Although the government had envisaged a target of sequencing five per cent of all positive samples from each state, a Business Standard analysis shows that it achieved 12 per cent of the targeted capacity.

Until January 10, data from INSACOG’s weekly bulletin (latest available) shows that the government could only sample 0.58 per cent of all positive cases starting January 2021. Even though higher than the 0.48 per cent sampling it had achieved in October 2021, it was still lower than the targeted capacity of 5 per cent.

Moreover, further analysis shows that none of the states could sequence 5 per cent of all their positive samples.

Data from the Indian Nucleotide Data Archive - Controlled Access (INDA-CA) portal shows that until January this year, 129,063 samples had been sent by states for genomic sequencing to INSACOG. Another 21,809 samples had been received via MoUs with state governments.

Of the 129,063 samples collected for genomic sequencing by INSACOG, five states accounted for 45 per cent of the samples.


Eleven of the 36 states and UTs had a genomic sequencing rate lower than the national average. The genomic sequencing rate is calculated by dividing the samples sent for genomic sequencing from the total number of positive cases in the state between December 31, 2020, and January 10, 2022.

While Sikkim had the highest genomic sequencing rate of 4.5 per cent, i.e., the state had sequenced 4.5 per cent of its positive cases, Bihar fared the worst, having sequenced only eight of the 10,000 positive cases.


Uttar Pradesh saw higher genomic sequencing than Bihar, but lower than the rest of the country. The state, until January 10, had carried out a genomic sampling of twenty out of every 10,000 positive cases.

Maharashtra and Kerala—states with the highest case count during this period—had sequenced 322 and 27 samples out of every 10,000 positive cases, respectively.

Telangana and West Bengal were the better performing states among the larger states. Telangana sequenced 251 out of every 10,000 positive cases, whereas West Bengal sequenced 129 samples.

As threats of new variants emerge, the government will need to step up its sampling capacity. An earlier analysis by Business Standard had found that in the data submitted to GISAID, a global initiative for sharing genomic data, 12 per cent of the samples in the country belonged to the other category. The “Others” category includes samples that cannot be classified under any variant.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus VaccineBihar

Next Story